NCT04663139
Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 1, 2020
Completion: Jun 26, 2021